Similar articles

• Laparoscopic-assisted hepatectomy (LAH) for the treatment of hepatocellular carcinoma.

  Miyazawa M, Oishi T, Isobe Y, Kubochi K, Ikeuchi S, Shima S, Kitajima M. Miyazawa M, et al. Surg Laparosc Endosc Percutan Tech. 2000 Dec;10(6):404-8. Surg Laparosc Endosc Percutan Tech. 2000. PMID: 11147919
• Recurrence of hepatocellular carcinoma after liver transplantation presenting with massive intrahepatic bleeding.

  Donadon M, Giacomoni A, Lauterio A, Slim A, Pirotta V, Mangoni I, De Carlis L. Donadon M, et al. Liver Transpl. 2008 Feb;14(2):259-61. doi: 10.1002/lt.21333. Liver Transpl. 2008. PMID: 18236411 No abstract available.
• Neither multiple tumors nor portal hypertension are surgical contraindications for hepatocellular carcinoma.

  Ishizawa T, Hasegawa K, Aoki T, Takahashi M, Inoue Y, Sano K, Imamura H, Sugawara Y, Kokudo N, Makuuchi M. Ishizawa T, et al. Gastroenterology. 2008 Jun;134(7):1908-16. doi: 10.1053/j.gastro.2008.02.091. Epub 2008 Mar 8. Gastroenterology. 2008. PMID: 18549877
• Prognosis of hepatocellular carcinoma.

  Llovet JM, Fuster J, Bruix J. Llovet JM, et al. Hepatogastroenterology. 2002 Jan-Feb;49(43):7-11. Hepatogastroenterology. 2002. PMID: 11941987 Review.
• [New surgical approaches in the treatment of hepatocellular carcinoma].

  Hoffmann K, Schmidt J. Hoffmann K, et al. Z Gastroenterol. 2009 Jan;47(1):61-7. doi: 10.1055/s-0028-1109097. Epub 2009 Jan 20. Z Gastroenterol. 2009. PMID: 19156593 Review. German.